One of the factors driving vaccination policy is societal value, one measure of which is cost-effectiveness. Unlike most U.S. public health institutions, the Advisory Committee on Immunization Practices explicitly considers cost-effectiveness in making recommendations.
No takes yet. Share an insight, caveat, or question.
Jane J. Kim (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: